← Home
/
SELLAS Life Sciences Group, Inc. (SLS)
Stock Analysis
SELLAS Life Sciences Group, Inc. (SLS)
SLS
SLS · Market data
7.76
+3.05%
Updated: 2026-06-18 13:35 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 9.31. Holding above 6.81 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Insufficient
✓
Price Structure
Constructive
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
6.81
↗
Break Above
Confirmation improves above resistance.
9.31
🎯
Next Objective
Pattern-derived target if setup continues.
1.91
×
Thesis Break
Scenario weakens below invalidation.
Below 6.81
What's Driving SLS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 9.31 for confirmation and 6.81 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 6.81 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
💵 Revenue
0.00
≈ Insufficient
📈 Net Income
-8.41M
≈ Insufficient
🧮 EPS (Basic)
-0.05
≈ Insufficient
SELLAS Life Sciences Group, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.